// App-Quantinova.ai

S1009 2015 AHA : Prevention of Diet-induced Metabolic Dysregulation, Inflammation and Atherosclerosis in Ldlr-/- Mice by Treatment with the ACL Inhibitor ETC-1002

Researchers

Presenter

  • Brian G Sutherland

Principal Investigators

  • Dawn E Telford

  • Cynthia G Sawyez

  • Jane Y Edwards

  • Sergey Filippov

  • Stephen L Pinkosky

  • Roger S Newton

  • Murray W Huff

Medical Centers

  • Robarts Reserach Institute, London, ON, Canada

  • University of Western Ontario, London, ON, Canada

Locations

  • Canada

Companies

  • Esperion Therapeutic

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Hypercholesterolemia, Familial, 1

  • Dyslipidemia

  • Coronary Artery Disease

  • Hyperglycemia

  • Fatty Liver Disease

  • Obesity

Biomarkers

  • N/A

Drug/Treatment

  • ESP55016

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved